Topical Brimonidine to Reduce Inflammation After IPL-treatment in Patients With Facial Telangiectasias

NCT02761174 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Telangiectasias

Interventions

DRUG: Brimonidine
OTHER: IPL+air-cooling

Sponsor

Merete Haedersdal

Collaborators

[object Object]
[object Object]